Remove Cardiothoracic Remove Heart Failure Remove Innovation
article thumbnail

2023 in Review: A Look at the Year's Top 10 Topics

DAIC

Joint Statement on Aortic Valve Replacement in Low-Risk Patients Issued by Society of Thoracic Surgeons and European Association for Cardiothoracic Surgeons 6. STOP-CA Clinical Trial Finds Statins Lower Rate of Heart Decline in Lymphoma Patients, Late-Breaking ACC23 Clinical Trial Reports 7.

article thumbnail

New Treatment Options Available for Patients with Tricuspid Valve Disease

DAIC

Traditionally, cardiothoracic surgeons have repaired or replaced the tricuspid valve during open-heart surgery and only when absolutely necessary; such surgeries are complex and risky. Catheter-based procedures offer an alternative for patients who are not candidates for open-heart surgery. Image by Getty.

article thumbnail

Medtronic Launches the Avalus Ultra Valve Engineered for Ease of Use at Implant and Lifetime Patient Management

DAIC

milla1cf Tue, 04/23/2024 - 15:53 April 23, 2024 — Medtronic plc, a global leader in healthcare technology, today announced the launch of its latest innovation in cardiac surgery, the Avalus Ultra valve. When the valve narrows, it does not open or close properly, making the heart work harder to pump blood throughout the body.

article thumbnail

Medtronic Launches the Avalus Ultra Valve Engineered for Ease of Use at Implant and Lifetime Patient Management

DAIC

Getty Images milla1cf Thu, 06/13/2024 - 20:38 June 13, 2024 — Medtronic plc, a global leader in healthcare technology, today announced the launch of its latest innovation in cardiac surgery, the Avalus Ultra valve. When the valve narrows, it does not open or close properly, making the heart work harder to pump blood throughout the body.

article thumbnail

Columbia Cardiology Launches New Mitral & Tricuspid Center

DAIC

Tricuspid and mitral valves are debilitating conditions that can lead to arrhythmias, hypertension, and heart failure. Until recently, therapeutic options for people with tricuspid and mitral valve disorders have been limited to symptom relief or high-risk surgery.

Tricuspid 111
article thumbnail

The Texas Heart Institute Collaborates on Multi-institutional DOD Grant to Develop Novel Left Ventricular Assist Device

DAIC

suffer from heart failure , and there are approximately 400,000 heart-failure-related deaths in this country each year. Patients with heart failure often experience reduced mobility, quality of life and ability to work; the disease also represents a significant public health care burden.

article thumbnail

Columbia Cardiology Launches New Mitral and Tricuspid Center

DAIC

Tricuspid and mitral valves are debilitating conditions that can lead to arrhythmias, hypertension, and heart failure. Until recently, therapeutic options for people with tricuspid and mitral valve disorders have been limited to symptom relief or high-risk surgery.